Xin-Xin Wen - Fourth Military Medical University

基本信息

Career Trajectory

Bio

Xin-Xin Wen currently works at the Department of Orthopaedics (Xijing), Fourth Military Medical University. Xin-Xin does research in Transfusion Medicine, Traumatology and Orthopedic Surgery. Their most recent publication is 'Ophiopogonin D improves osteointegration of titanium alloy implants under diabetic conditions by inhibition of ROS overproduction via Wnt/β-catenin signaling pathway'.

Research Interests

Papers共 41 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Simultaneous Detection of Volatile and Non-Volatile Metabolites in Urine Using UPLC-Q-Exactive Orbitrap-MS and HS-SPME/GC-HRMS: A Promising Strategy for Improving the Breast Cancer Diagnosis Accuracy

Xian Li,Xinxin Wen, Zewei Luo,Xuejun Wang,Yilin Zhang,Jing Wei,Yonghui Tian,Rui Ling,Yixiang Duan

Talanta (2025): 127812-127812

Cited0Views0WOSBibtex

Efficacy and Safety of Recombinant Humanized Anti-Her2 Antibody-Mmae Conjugate (RC48) in Neoadjuvant for HER2-positive Breast Cancer: A Single-Arm Phase II Study

Jixin Yang,Yuqing Yang,Xinxin Wen,Jiang Wu,Jing Yu,Lei Wang,Wenyu Hu,Dongdong Xu, Jialing Luo,Wen Ma,Nanlin Li

Journal of Clinical Oncology（2024）

Cited0Views0Bibtex

A Historical Controlled Study of Domestic Trastuzumab and Pertuzumab in Combination with Docetaxel for the Neoadjuvant Treatment of Early HER2-positive Breast Cancer

Dongdong Xu,Jiang Wu,Jing Yu,Yuqing Yang,Xinxin Wen,Jixin Yang,Hongliang Wei,Xiaolong Xu,Yike Li,Liu Yang,Lei Wang,Yijia Wang,Wen Ma,Nanlin Li

Frontiers in Oncology（2024）

Cited0Views0WOSBibtex

Clinical Practice Guidelines for Neoadjuvant Therapy in Patients with Early-Stage Breast Cancer: Chinese Society of Breast Surgery Practice Guidelines 2022

Juliang Zhang,Ting Wang,Zhe Wang,Jing Fan,Xiaolong Xu,Jing Kong,Xinxin Wen,Rui Ling,Yinhua Liu

CHINESE MEDICAL JOURNALno. 12 (2024): 1387-1388

Cited0Views0WOSBibtex

Identifying Potential Breath Biomarkers for Early Diagnosis of Papillary Thyroid Cancer Based on Solid-Phase Microextraction Gas Chromatography-High Resolution Mass Spectrometry with Metabolomics

Lan Li,Xinxin Wen, Xian Li, Yaqi Yan,Jiayu Wang,Xuyang Zhao,Yonghui Tian,Rui Ling,Yixiang Duan

Metabolomicsno. 3 (2024)

Cited0Views0WOSBibtex

A Phase II Study of Neoadjuvant PLD/Cyclophosphamide and Sequential Nab-Paclitaxel Plus Dual HER2 Blockade in HER2-Positive Breast Cancer

Ji-Xin Yang,Yu-Qing Yang,Wen-Yu Hu,Lu Yang,Jiang Wu,Xin-Xin Wen,Jing Yu,Mei-Ling Huang,Dong-Dong Xu,Dan-Chen Tie,Lei Wang,Fan-Fan Li,Nan-Lin Li

ONCOLOGIST（2024）

Cited2Views0WOSBibtex

乳腺癌HER-2低表达人群的靶向治疗新选择研究进展

FENG Zihang,LI Nanlin,WEN Xinxin

Chinese Journal of Cancer Prevention and Treatmentno. 9 (2023)

Cited0Views0Bibtex

Development of a Headspace-Solid Phase Microextraction Gas Chromatography-High Resolution Mass Spectrometry Method for Analyzing Volatile Organic Compounds in Urine: Application in Breast Cancer Biomarker Discovery

Xian Li,Xinxin Wen,Zewei Luo,Yonghui Tian,Cheng Qian,Jing Zhang,Rui Ling,Yixiang Duan

CLINICA CHIMICA ACTA（2023）

Cited2Views0WOSBibtex

Neoadjuvant Pegylated Liposomal Doxorubicin (PLD) Plus Cyclophosphamide Followed by Nab-Paclitaxel (Nab-P) As Primary Chemotherapy Continuously Combined with Dual HER2 Blockage for HER2-positive Breast Cancer: A Single-Arm Phase 2 Trial (brecan Trial)

Jixin Yang,Yuqing Yang,Xinxin Wen,Jiang Wu,Jing Yu,Lei Wang,Meiling Huang,Wenyu Hu,Wen Ma,Nanlin Li

JOURNAL OF CLINICAL ONCOLOGY（2022）

Cited1Views0Bibtex

Diagnostic Approach to Thyroid Cancer Based on Amino Acid Metabolomics in Saliva by Ultra-Performance Liquid Chromatography with High Resolution Mass Spectrometry

Jing Zhang,Xinxin Wen,Yuting Li, Xian Li,Cheng Qian,Yonghui Tian,Rui Ling,Yixiang Duan

TALANTA（2021）

Cited24Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn